Celebrity endorsements by Elon Musk and Serena Williams have pushed weight loss medication into the mainstream. Demand is so ...
Trump announced popular weight loss treatments would be offered directly on a new “TrumpRx.gov” website at lower prices.
New research suggests GLP-1 weight-loss drugs like Ozempic and Zepbound may reduce cravings for alcohol and drugs by ...
Novo Nordisk cuts obesity drug prices to compete with Eli Lilly, offering new patient deals and nationwide access.
The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster ...
Novo Nordisk A/S is undercutting archrival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to ...
Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that ...
Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...
Novo Nordisk announced it is cutting the cash-pay pricing for its popular semaglutide drugs: Wegovy will now be offered at ...
Novo revealed Monday that the self-pay cost for the two lowest dosages of Wegovy and Ozempic will be $349 per month, down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results